Evidence map›Paper›PMID 42403858›Full record

ArticleCureus2026

Autosomal Dominant Obstructive Sleep Apnea Syndrome Due to the New Variant c.980_984dup in COL1A2: A Case Report.

Josef Finsterer

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Josef FinstererNeurology, Neurology and Neurophysiology Center, Vienna, AUT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obstructive sleep apnea syndrome (OSAS) is a complex disorder characterized by the collapse of the upper airway during sleep. Although a family history often suggests a hereditary predisposition to OSAS, there is little evidence that it is actually a monogenic disorder. To date, no case of a patient with hereditary OSAS due to a pathogenic mutation in the collagen type I alpha-2 chain (COL1A2) gene has been described. The patient was a 72-year-old woman who had suffered from insomnia since the age of 35. OSAS was suspected since then, but was only confirmed at the age of 67 by polysomnography. The OSAS was treated with nocturnal active positive airway pressure (APAP), which led to an improvement. Her medical history also included joint hypermobility, brachydactyly, multiple nevi, an umbilical hernia, left-sided tinnitus and hearing impairment, hair loss, hip pain, and ptosis. Since her son also developed OSAS at the age of 34, hereditary OSAS was suspected, and exome sequencing was performed, which revealed the novel variant c.980_984dup (p.Ile329Alafs*72) in the COL1A2 gene. Since OSAS is a known complication of connective tissue disorders (CTDs), the index patient's OSAS was attributed to the COL1A2 mutation. This case suggests that OSAS may be hereditary due to a variant in the COL1A2 gene and may represent the dominant phenotypic feature. Physicians should be aware that OSAS can be hereditary; therefore, CTD patients with a positive family history of OSAS should undergo genetic testing for variants in genes associated with CTD.

Indexed as

col1a2 variantcpaphearing lossptosissleep apnea syndrome

Identifiers

PMID42403858
PMCPMC13333180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.